Search results for " isotretinoin"

showing 2 items of 2 documents

A randomized trial assessing the effectiveness of different concentrations of isotretinoin in the management of lichen planus

2004

The aim of our 10-year study was to test the effectiveness of topical therapy based on 0. 18% isotretinoin, comparing it with that most frequently used, i.e. at 0.05% concentration. Seventy patients with an established diagnosis of oral lichen planus were involved in the study. The patients were randomly divided into two groups, and the drug was administered topically at 0.05% and 0. 18% concentrations. The drug at the higher concentration, according to the same protocol, was administered to the patients who did not benefit from the therapy at the lower concentration. None of the cases of reticular lichen planus showed clinical or histological improvement. In contrast, the atrophic-erosive …

AdultMaleDrugmedicine.medical_specialtyHot TemperatureRandomizationAdministration Topicalmedicine.medical_treatmentmedia_common.quotation_subjectSensationPainoral lichen planus isotretinoinlaw.inventionRandomized controlled trialRecurrencelawOral and maxillofacial pathologyHumansMedicineIsotretinoinOral UlcerIsotretinoinAgedmedia_commonChemotherapybusiness.industrySmokingMiddle Agedmedicine.diseaseDermatologyClinical trialstomatognathic diseasesTreatment OutcomeOtorhinolaryngologyFemaleSurgeryOral lichen planusDermatologic AgentsOral SurgerybusinessFollow-Up StudiesLichen Planus Oralmedicine.drug
researchProduct

Evaluation of the clinical and histological effectiveness of isoretinoin in the therapy of oral leukoplakia. Ten years of experience: is management s…

2006

Various studies have evaluated the therapeutic effectiveness of vitamin A derivatives in the treatment of oral leukoplakia (OL). Not all the studies have shown concordant results. The aim of our study, which has a 10-year follow-up, was to test the effectiveness of topical therapy based on 0.18% isotretinoin by comparing it with that most frequently used, i.e., at 0.05% concentration. Forty patients with an established diagnosis of OL were involved in the study. The patients were randomly divided into two groups and the drug was administered topically at 0.05% and 0.18% concentrations. The drug was applied twice a day for 3 consecutive months; then it was suspended for 1 month, and the biop…

MaleDrugVitaminmedicine.medical_specialtyAdministration Topicalmedia_common.quotation_subjectlaw.inventionchemistry.chemical_compoundKeratolytic AgentsRandomized controlled trialRecurrencelawmedicineHumansEstablished diagnosisIsotretinoinIsotretinoinAgedmedia_commonLeukoplakiaDose-Response Relationship Drugbusiness.industryoral leukoplakia isotretinoinHistologyMiddle Agedmedicine.diseaseDermatologySurgeryOral leukoplakiachemistryFemaleLeukoplakia Oralbusinessmedicine.drug
researchProduct